Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

© John Cairns

Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis.

Journal article

Hesari E. et al, (2026), J Diabetes Metab Disord, 25

Predicting trajectories of illness using RNA velocity of whole blood.

Journal article

Dunican C. et al, (2026), Nat Commun, 17

Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Journal article

GBD 2023 Meningitis & Antimicrobial Resistance Collaborators ., (2026), Lancet Neurol, 25, 451 - 468

Load More